When multiple myeloma returns after initial treatment, accessing specialized expertise becomes critical. A second opinion can reveal novel therapies, clinical trials, and treatment sequencing strategies that community oncologists may not routinely offer. Key Takeaways Gather thorough medical records, FISH panels, imaging, treatment timelines, before contacting specialists to enable accurate relapse assessment Target specialists with high relapsed-myeloma case volume, CAR-T th

Relapsed multiple myeloma demands treatment decisions grounded in current cytogenetic risk profiles, prior therapy history, and access to novel agents. A second opinion helps clarify next-line therapy eligibility and investigational pathways. Key Takeaways Symptomatic relapse with organ damage requires urgent specialist review, while asymptomatic M-protein rise allows scheduled consultations over weeks. Prepare four core documents before consultation: pathology report with FI